Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1994 1
1997 2
2004 2
2006 1
2008 3
2009 4
2010 5
2011 8
2012 15
2013 14
2014 14
2015 12
2016 13
2017 3
2018 3
2019 1
2022 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 23482777

88 results
Results by year
Filters applied: . Clear all
Page 1
Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial.
Katsumata N, Yasuda M, Isonishi S, Takahashi F, Michimae H, Kimura E, Aoki D, Jobo T, Kodama S, Terauchi F, Sugiyama T, Ochiai K; Japanese Gynecologic Oncology Group. Katsumata N, et al. Lancet Oncol. 2013 Sep;14(10):1020-6. doi: 10.1016/S1470-2045(13)70363-2. Epub 2013 Aug 13. Lancet Oncol. 2013. PMID: 23948349 Clinical Trial.
Paclitaxel/carboplatin with or without sorafenib in the first-line treatment of patients with stage III/IV epithelial ovarian cancer: a randomized phase II study of the Sarah Cannon Research Institute.
Hainsworth JD, Thompson DS, Bismayer JA, Gian VG, Merritt WM, Whorf RC, Finney LH, Dudley BS. Hainsworth JD, et al. Cancer Med. 2015 May;4(5):673-81. doi: 10.1002/cam4.376. Epub 2014 Dec 31. Cancer Med. 2015. PMID: 25556916 Free PMC article. Clinical Trial.
88 results